BURLINGTON, ON, Nov. 2, 2022
/CNW/ - EcoSynthetix Inc. (TSX: ECO) ("EcoSynthetix" or the
"Company"), a renewable chemicals company that produces a
portfolio of commercially proven bio-based products, today
announced its financial and operational results for the three
months (Q3 2022) and nine months (YTD 2022) ended September 30, 2022. Financial references are in
U.S. dollars unless otherwise indicated.
Highlights
(Comparison periods in each case are the
three months ended September 30,
2021)
- Recorded net sales of $5.0
million in Q3 2022, up 7%, due to higher average selling
price of 28%, partly offset by lower volumes of 21%
- Gross profit of $1.0 million in
Q3 2022, down 6%, due to lower volumes and higher manufacturing
costs which offset higher average selling price
- Recorded an Adjusted EBITDA1 loss of $0.1 million in Q3 2022, unchanged from the prior
period
- Purchased and cancelled 133,600 common shares in Q3 2022 under
the normal course issuer bid for total consideration of
$0.4 million
- Maintained a strong balance sheet with cash and term deposits
of $36.9 million as at September 30, 2022
- Won a new account for the Company's SurfLock™ strength aids in
the wet-end vertical with a leading European packaging and paper
group, this new account represents the third win and the Company's
largest account in the wet-end vertical during the past 12
months
- The Company's partner in personal care products, Dow, announced
that MaizeCare™ Clarity Polymer, a bio-based and biodegradable
polymer with film-forming properties for crystal clear
formulations, won two prestigious innovation awards, a 2022 R&D
100 Award from R&D Magazine and named a Sustainability Product
of the Year by Business Intelligence Groups (BIG™)
- CEO Jeff MacDonald was named to
Canada's 2023 Clean16 as a leader
in clean technology at the Clean50 awards, which recognizes
sustainability leaders in Canada
for their contributions over the prior two years
"The business continues to demonstrate resiliency, with top-line
growth and consistent performance on the bottom line in the face of
very challenging macro-economic and supply chain conditions," said
Jeff MacDonald, CEO of EcoSynthetix.
"This performance is a result of the continued diversification of
our revenue mix, most recently with a new account win in the
wet-end strength aids vertical. Our existing account base remains
solid as customers continue to recognize the value proposition,
performance and carbon footprint benefits of our all-natural,
bio-based binders within their production processes, supply chains
and end products. Underlying market conditions continue to be
challenging; specifically with respect to raw materials
availability and the impact of supply chain constraints and
inflation on pricing. We are actively managing these
conditions by building inventory and broadening our supplier base
to ensure our key accounts and long-standing relationships receive
adequate supply and, as evidenced by the additional raw materials
we secured in the quarter, begin to support important new growth
opportunities."
Financial Summary
Net Sales
Net sales were $5.0 million and
$13.4 million for Q3 2022 and YTD
2022, respectively, compared to $4.7
million and $13.3 million for
the corresponding periods in 2021. The 7% increase in the quarterly
period was due to higher average selling price of $1.3 million, or 28%, which was partly offset by
lower volumes which impacted sales by $1.0
million or 21%. Sales volumes were impacted by unfavorable
market conditions, primarily in graphic paper, and limited
feedstock availability due to challenging supply chain conditions.
The drivers behind the increase in the YTD period were consistent
with the quarterly period, higher average selling price of
$3.8 million, or 29%, partly offset
by lower volumes for the same reasons as in the quarter which
impacted sales by $3.7 million, or
28%.
Gross Profit
Gross profit was $1.0 million and
$3.2 million for Q3 2022 and YTD
2022, respectively, compared to $1.1
million and $3.0 million for
the corresponding periods in 2021. During both periods, a higher
average selling price was offset by decreases in sales volumes and
rising costs of manufacturing.
Gross profit as a percentage of sales was 20.6% and 24.1% for Q3
2022 and YTD 2022, respectively, compared to 23.5% and 22.3% for
the corresponding periods in 2021. Gross profit as a percentage of
sales adjusted for manufacturing depreciation was 23.0% and 27.3%
for Q3 2022 and YTD 2022, respectively, compared to 27.8% and 26.7%
for the corresponding periods in 2021. The change in the quarterly
periods was due to higher costs of manufacturing partly offset by a
higher average selling price. The improvement in the YTD
period was primarily due to a higher average selling price partly
offset by higher manufacturing costs.
Selling, General and Administrative
Selling, general and administrative expenses (SG&A) were
$1.1 million and $3.9 million for Q3 2022 and YTD 2022,
respectively, compared to $1.4
million and $3.9 million for
the corresponding periods in 2021. The improvement in the quarterly
period was primarily due to a reduction in the provision for
variable compensation of $0.2
million. The YTD period was in line with the prior period,
due to lower provision for variable compensation of $0.4 million which was offset by lower payments
received under the Canadian Emergency Wage Subsidy program of
$0.1 million, and increased
discretionary spend.
Research and Development
Research and development (R&D) costs were $0.4 million and $1.4
million for Q3 2022 and YTD 2022, respectively, which were
in line with $0.5 million and
$1.4 million in the corresponding
periods in 2021. R&D expense as a percentage of sales were 9%
and 10% for Q3 2022 and YTD 2022, respectively, compared to 10% for
each of the corresponding periods in 2021. The Company's R&D
efforts continue to focus on further enhancing value for our
existing products and expanding addressable opportunities.
Adjusted EBITDA1
Adjusted EBITDA loss was $0.1
million and $0.5 million for
Q3 2022 and YTD 2022, respectively, which was in line with
$0.1 million and $0.6 million during the corresponding periods in
2021. The drivers of Adjusted EBITDA in the quarterly period were
lower gross profit offset by lower operating costs compared to the
prior year period. The drivers in the YTD period were higher gross
profit offset by higher operating costs.
Net Loss
Net loss was $0.4 million, or
$0.01 per common share, and
$1.7 million, or $0.03 per common share, for Q3 2022 and YTD 2022,
respectively, compared to $0.8
million, or $0.01 per common
share, and $2.2 million, or
$0.04 per common share, for the
corresponding periods in 2021. The improvement in the quarterly
period was due to a lower loss from operations of $0.2 million and higher interest income of
$0.1 million. The improvement in the
YTD period was primarily due to lower loss from operations of
$0.3 million and higher interest
income of $0.2 million. The higher
interest income in both periods was due to an increase in interest
rates on cash and term deposits.
Liquidity
Cash on hand and term deposits were $36.9
million as at September 30,
2022, compared to $42.2
million as at December 31,
2021. The $5.3 million change
was primarily due to an increase in inventory of $2.6 million, an increase in accounts receivable
of $0.6 million, and $1.4 million of cash used to purchase shares
through the NCIB. The Company purchased and cancelled 133,600 and
361,200 common shares under the normal course issuer bid during the
Q3 2022 and YTD 2022 periods, respectively, for consideration of
$0.4 million and $1.4 million.
Notice of Conference Call
EcoSynthetix will host a conference call Thursday, November 3, 2022, at 8:30 AM ET to discuss its financial results.
Jeff MacDonald, CEO, and
Robert Haire, CFO, will co-chair the
call. All interested parties can join the call by dialling (416)
764-8659 or (888) 664-6392 with the conference identification of
32926019. Please dial in 15 minutes prior to the call to secure a
line. A live audio webcast of the conference call will also be
available at www.ecosynthetix.com. The presentation will be
accompanied by slides, which will be available via the webcast link
and the Company's website. Please connect at least 15 minutes prior
to the conference call to ensure adequate time for any software
download that may be required to join the webcast.
1Non-IFRS Financial Measures
This press release makes reference to certain non-IFRS measures.
These non-IFRS measures are not recognized measures under IFRS, do
not have a standardized meaning prescribed by IFRS and are
therefore unlikely to be comparable to similar measures presented
by other companies. Rather, these measures are provided as
additional information to complement those IFRS measures by
providing a further understanding of results of operations of
EcoSynthetix from management's perspective. Accordingly, they
should not be considered in isolation nor as a substitute for
analysis of the financial information of EcoSynthetix reported
under IFRS. The Company uses non-IFRS measures such as Adjusted
EBITDA to provide investors with a supplemental measure of
operating performance and thus highlight trends in its core
business that may not otherwise be apparent when relying solely on
IFRS financial measures. Management also believes that securities
analysts, investors and other interested parties frequently use
non-IFRS measures in the evaluation of issuers. Management also
uses non-IFRS measures in order to facilitate operating performance
comparisons from period to period, prepare annual operating budgets
and assess the Company's ability to meet its capital expenditure
and working capital requirements.
Adjusted EBITDA is not a measure recognized under IFRS and does
not have a standardized meaning prescribed by IFRS. See "IFRS and
Non-IFRS Measures." The Company presents Adjusted EBITDA because
the Company believes it facilitates investors' use of operating
performance comparisons from period to period and company to
company by backing out potential differences caused by variations
in capital structures (affecting relative interest expense), the
book amortization of intangibles (affecting relative amortization
expense) and the age and book value of property and equipment
(affecting relative depreciation expense). The Company also
presents Adjusted EBITDA because it believes it is frequently used
by securities analysts, investors and other interested parties as a
measure of financial performance. Adjusted EBITDA as presented
herein are not recognized measures under IFRS and should not be
considered as an alternative to operating income or net income as
measures of operating results or an alternative to cash flows as
measures of liquidity. Adjusted EBITDA is defined as consolidated
net income (loss) before net interest expense, income taxes,
depreciation, amortization, other non-cash expenses and charges
deducted in determining consolidated net income (loss).
The following table reconciles net loss to Adjusted EBITDA loss
for the three months and nine months ended September 30, 2022 and September 30, 2021:
|
Three months
ended
September 30, 2022
|
Three months
ended
September 30, 2021
|
Nine months
ended
September 30, 2022
|
Nine months
ended
September 30, 2021
|
Net Loss
|
(388,850)
|
(763,892)
|
(1,724,570)
|
(2,242,873)
|
Depreciation
|
228,313
|
357,902
|
741,172
|
1,056,445
|
Share-based
Compensation
|
186,034
|
300,300
|
709,301
|
647,262
|
Interest
Income
|
(156,968)
|
(10,317)
|
(271,954)
|
(51,927)
|
Adjusted EBITDA
loss
|
(131,471)
|
(116,007)
|
(546,051)
|
(591,093)
|
About EcoSynthetix Inc. (www.ecosynthetix.com)
EcoSynthetix, a 2022 climate positive company, offers a range of
sustainable engineered biopolymers that allow customers to reduce
their use of harmful materials, such as formaldehyde and
styrene-based chemicals. The Company's flagship products,
DuraBind™, Bioform™, and EcoSphere®, are used to manufacture wood
composites, personal care, and paper and packaging, and enable
performance improvements, economic benefits and carbon footprint
reduction. The Company is publicly traded on the Toronto Stock
Exchange (T:ECO).
Forward-Looking Statements
Certain statements in
this Press Release constitute "forward-looking" statements that
involve known and unknown risks, uncertainties and other factors
which may cause the actual results, performance, objectives or
achievements of the Company, or industry results, to be materially
different from any future results, performance, objectives or
achievements expressed or implied by such forward looking
statements. The forward-looking statements in this Press Release
include, but are not limited to, statements regarding the Company's
plans to execute its commercial strategy, deliver meaningful growth
across all three product categories, convert high-value strategic
prospects into customers, and other statements regarding the
Company's plans and expectations in 2022. These statements reflect
our current views regarding future events and operating performance
and are based on information currently available to us, and speak
only as of the date of this Press Release. These forward-looking
statements involve a number of risks, uncertainties and assumptions
and should not be read as guarantees of future performance or
results, and will not necessarily be accurate indications of
whether or not such performance or results will be achieved. Those
assumptions and risks include, but are not limited to, the
Company's ability to successfully allocate capital as needed and to
develop new products, as well as the fact that our results of
operations and business outlook are subject to significant risk,
volatility and uncertainty. Many factors could cause our actual
results, performance or achievements to be materially different
from any future results, performance or achievements that may be
expressed or implied by such forward-looking statements, including
the factors identified in the "Risk Factors" section of the
Company's Annual Information Form dated February 24, 2022. Should one or more of these
risks or uncertainties materialize, or should assumptions
underlying the forward-looking statements prove incorrect, actual
results may vary materially from those described in this Press
Release as intended, planned, anticipated, believed, estimated or
expected. Unless required by applicable securities law, we do not
intend and do not assume any obligation to update these
forward-looking statements.
EcoSynthetix
Inc.
|
|
|
Interim Consolidated
Balance Sheets
|
|
|
(expressed in US
dollars)
|
|
|
|
|
|
|
|
|
|
September 30,
2022
|
December 31,
2021
|
Assets
|
|
|
|
|
|
Current
assets
|
|
|
Cash
|
9,182,319
|
42,226,816
|
Term
deposits
|
17,581,074
|
-
|
Accounts
receivable
|
2,534,130
|
1,912,390
|
Inventory
|
4,726,961
|
2,073,800
|
Government grants
receivable
|
24,443
|
6,676
|
Prepaid
expenses
|
136,518
|
91,930
|
|
34,185,445
|
46,311,612
|
|
|
|
Non-current
assets
|
|
|
Term
deposits
|
10,101,490
|
-
|
Property, plant and
equipment
|
4,069,909
|
4,670,089
|
|
14,171,399
|
4,670,089
|
|
|
|
Total
assets
|
48,356,844
|
50,981,701
|
|
|
|
|
|
|
Liabilities
|
|
|
|
|
|
Current
liabilities
|
|
|
Trade accounts payables
and accrued liabilities
|
2,313,726
|
2,363,630
|
|
|
|
Non-current
liabilities
|
|
|
Lease
liability
|
568,714
|
820,045
|
|
|
|
Total
liabilities
|
2,882,440
|
3,183,675
|
Shareholders'
Equity
|
|
|
Common
shares
|
491,218,118
|
492,297,041
|
Contributed
surplus
|
10,331,862
|
9,851,991
|
Accumulated
deficit
|
(456,075,576)
|
(454,351,006)
|
Total shareholders'
equity
|
45,474,404
|
47,798,026
|
|
|
|
Total liabilities
and shareholders' equity
|
48,356,844
|
50,981,701
|
EcoSynthetix
Inc.
|
|
|
|
|
|
Interim Consolidated
Statements of Operations and Comprehensive Loss
|
|
|
|
|
|
For the three and
nine months ended September 30, 2022 and 2021
|
|
|
|
|
(expressed in US
dollars)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three months
ended September 30,
|
|
Nine months
ended September 30,
|
|
2022
|
2021
|
|
2022
|
2021
|
|
|
|
|
|
|
Net
sales
|
5,019,650
|
4,705,917
|
|
13,425,443
|
13,276,471
|
|
|
|
|
|
|
Cost of
sales
|
3,984,789
|
3,602,241
|
|
10,193,057
|
10,318,220
|
|
|
|
|
|
|
Gross profit on
sales
|
1,034,861
|
1,103,676
|
|
3,232,386
|
2,958,251
|
|
|
|
|
|
|
Expenses
|
|
|
|
|
|
Selling, general and
administrative
|
1,146,576
|
1,394,430
|
|
3,862,642
|
3,888,241
|
Research and
development
|
434,103
|
483,455
|
|
1,366,268
|
1,364,810
|
|
1,580,679
|
1,877,885
|
|
5,228,910
|
5,253,051
|
|
|
|
|
|
|
Loss from
operations
|
(545,818)
|
(774,209)
|
|
(1,996,524)
|
(2,294,800)
|
|
|
|
|
|
|
Net interest
income
|
156,968
|
10,317
|
|
271,954
|
51,927
|
Net loss and
comprehensive loss
|
(388,850)
|
(763,892)
|
|
(1,724,570)
|
(2,242,873)
|
|
|
|
|
|
|
Basic and diluted
loss per common share
|
(0.01)
|
(0.01)
|
|
(0.03)
|
(0.04)
|
Weighted average
number of common shares outstanding
|
58,809,507
|
57,277,143
|
|
58,866,452
|
57,251,786
|
EcoSynthetix
Inc.
|
|
|
|
|
|
Interim Consolidated
Statements of Cash Flows
|
|
|
|
|
|
For the three and
nine months ended September 30, 2022 and 2021
|
|
|
|
(expressed in US
dollars)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three months
ended September 30,
|
|
Nine months
ended September 30,
|
|
2022
|
2021
|
|
2022
|
2021
|
Cash provided by
(used in)
|
|
|
|
|
|
|
|
|
|
|
|
Operating
activities
|
|
|
|
|
|
Net loss and
comprehensive loss
|
(388,850)
|
(763,892)
|
|
(1,724,570)
|
(2,242,873)
|
Items not affecting
cash
|
|
|
|
|
|
Depreciation
|
228,313
|
357,902
|
|
741,172
|
1,056,445
|
Share-based
compensation
|
186,034
|
300,300
|
|
709,301
|
647,262
|
Other
|
66,996
|
13,675
|
|
77,532
|
80,529
|
Changes in non-cash
working capital
|
|
|
|
|
|
Accounts
receivable
|
(830,624)
|
(250,459)
|
|
(621,740)
|
(457,356)
|
Inventory
|
(1,914,302)
|
45,548
|
|
(2,586,046)
|
(498,296)
|
Government grants
receivable
|
(7,889)
|
31,447
|
|
(17,767)
|
99,735
|
Prepaid expenses
|
26,785
|
(27,273)
|
|
(44,588)
|
(62,459)
|
Trade accounts payables and
accrued liabilities
|
622,350
|
344,174
|
|
(22,039)
|
1,217,589
|
Interest on term
deposits
|
|
|
|
|
|
Interest received on term deposits
|
-
|
-
|
|
-
|
358,740
|
Accrued interest on term deposits
|
(76,043)
|
-
|
|
(182,564)
|
(14,165)
|
|
(2,087,230)
|
51,422
|
|
(3,671,309)
|
185,151
|
|
|
|
|
|
|
Investing
activities
|
|
|
|
|
|
Purchase of property,
plant and equipment
|
(34,975)
|
(107,154)
|
|
(233,461)
|
(345,502)
|
Receipts of government
grants related to property, plant and equipment
|
-
|
67,418
|
|
-
|
67,418
|
Receipts on mature term
deposits
|
-
|
-
|
|
-
|
25,000,000
|
Purchase of term
deposits
|
(7,500,000)
|
-
|
|
(27,500,000)
|
-
|
|
(7,534,975)
|
(39,736)
|
|
(27,733,461)
|
24,721,916
|
|
|
|
|
|
|
Financing
activities
|
|
|
|
|
|
Payments made on lease
liability
|
(68,499)
|
(63,443)
|
|
(200,134)
|
(185,638)
|
Common shares
repurchased
|
(442,369)
|
(400,105)
|
|
(1,444,585)
|
(797,998)
|
Exercise of common
share options
|
136,232
|
40,262
|
|
136,232
|
260,355
|
|
(374,636)
|
(423,286)
|
|
(1,508,487)
|
(723,281)
|
|
|
|
|
|
|
|
|
|
|
|
|
Effect of exchange rate
changes on cash
|
(113,692)
|
(40,727)
|
|
(131,240)
|
(69,685)
|
|
|
|
|
|
|
Change in cash
during the period
|
(10,110,533)
|
(452,327)
|
|
(33,044,497)
|
24,114,101
|
|
|
|
|
|
|
Cash - Beginning of
period
|
19,292,852
|
41,203,589
|
|
42,226,816
|
16,637,161
|
|
|
|
|
|
|
Cash - End of
period
|
9,182,319
|
40,751,262
|
|
9,182,319
|
40,751,262
|
SOURCE EcoSynthetix Inc.